Gemmer Asset Management LLC Spectrum Pharmaceuticals Inc Transaction History

Gemmer Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 01, 2020	SELL	$1.83 - $3.45 $589 - $1,110	-322 Closed	0 $0
Q3 2019 Oct 11, 2019	BUY	$7.03 - $9.7 $231 - $320	33 Added 11.42%	322 $3,000
Q2 2019 Jul 18, 2019	BUY	$7.36 - $11.26 $353 - $540	48 Added 19.92%	289 $2,000
Q4 2018 Jan 18, 2019	BUY	$6.39 - $16.99 $1,539 - $4,094	241 New	241 $2,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.